language_icon
EN
HI

Biogen Pharmachem Industries Share price

BIOGEN

0.37

0.00 (0.00%)
Last updated on 25 May, 2026 | 07:50 IST
Today's High

00

Today's Low

00

52 Week Low

0.34

52 Week High

0.92

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Biogen Pharmachem Industries Chart

Biogen Pharmachem Industries Share Key Metrics

Volume
0.00
Market Cap
38.96 CR
LTQ@LTP
0@0.37
ATP
0
Var Margin
28.26 %
Circuit Range
0.3-0.44
Delivery %
63.09 %
Value
0.00
ASM/GSM
No
Market Lot
1

Summary

Biogen Pharmachem Industries share price is ₹0.37 as of 25 May, 2026. The stock Biogen Pharmachem Industries intraday movement has stayed between ₹00 and ₹00, while on a 52-week basis,Biogen Pharmachem Industries price 52 week high is ₹0.92 & its 52 week low is ₹0.34.
In terms of trading activity, Biogen Pharmachem Industries has recorded a volume of 0 shares, The Biogen Pharmachem Industries has a market cap of ₹1053036833 CR. The stock’s Average Traded Price (ATP) stands at ₹0.00, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 0 @ ₹0.37.
Biogen Pharmachem Industries operates within a circuit range of ₹0.30 – ₹0.44, with a Value of ₹0.00. The Delivery Percentage for the day is 63.09%. Additionally, Biogen Pharmachem Industries currently falls under the No framework, and trades with a market lot size of 1.

Biogen Pharmachem Industries Fundamentals

View More
P/E Ratio

0

P/B Ratio

0

Div. Yield

0

Sector P/E

41.49

Sector P/B

2.06

Sec. Div. Yield

79.52

Biogen Pharmachem Industries Resistance and Support

Pivot 0.37

Resistance

First Resistance

0.38

Second Resistance

0.38

Third Resistance

0.39

Support

First Support

0.37

Second Support

0.36

Third Support

0.36

Biogen Pharmachem Industries Shareholding Pattern

View More
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

0%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

0%

Domestic Institutional Investors

0%

Retail

100%

Others

0%

Total Promoters
MAR '26
0%

Biogen Pharmachem Industries Corporate Actions

DateAgenda
2026-05-14Audited Results
2026-03-23Bonus issue
2026-02-11Quarterly Results
2026-02-03Quarterly Results
2025-11-07Quarterly Results
2025-07-23Quarterly Results
2025-05-23Audited Results
2025-02-05Quarterly Results & Others

Biogen Pharmachem Industries News

Biogen Pharmachem Industries Ltd - 531752 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Rama Shiva Lease Finance Private Limited disposed of 5.26% stake in Biogen Pharmachem on May 18, 2026. This reduces their total holding from 9.31% to 4.04% through an open market transaction.
May 20 2026 10:05:00

Biogen Pharmachem Industries Ltd - 531752 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

RAMA SHIVA LEASE FINANCE PRIVATE LIMITED disposed of 5.26% stake in Biogen Pharmachem through an open market transaction. This reduces their holding from 9.31% to 4.04%, signaling a significant reduction by a major shareholder.
May 20 2026 10:05:00

Biogen Pharmachem Industries Ltd - 531752 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Parichay Infrastructure Limited sold 3.99 crore shares of Biogen Pharmachem, decreasing its shareholding from 9.08% to 4.66%. This transaction was executed through an open market sale on May 18, 2026.
May 20 2026 09:05:00

Biogen Pharmachem Industries Ltd - 531752 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Interface Financial Services Limited sold 4.47% stake in Biogen Pharmachem, reducing its total shareholding from 9.31% to 4.84%. The transaction was executed via an open market sale.
May 19 2026 17:05:00

Biogen Pharmachem Industries Ltd - 531752 - Announcement under Regulation 30 (LODR)-Allotment

Biogen Pharmachem allotted 15.04 crore bonus equity shares, increasing its paid-up and issued capital from Rs. 90.26 crore to Rs. 105.30 crore. The shares were credited to shareholder accounts on May 18, 2026.
May 18 2026 17:05:00

Biogen Pharmachem Industries Ltd - 531752 - Board Meeting Outcome for Audited Financial Results Of The Company For The Quarter And Year Ended On 31St March, 2026 And Outcome Of The Board Meeting Held On Thursday 14Th May 2026.

Biogen Pharmachem's board approved audited FY26 financial results, with revenue at ₹255.80 lacs and a net profit of ₹85.95 lacs. This marks a substantial turnaround, with revenue growing 205% YoY and the company moving from a net loss to profitability, as confirmed by an unmodified audit opinion.
May 14 2026 16:05:00

Biogen Pharmachem Industries Ltd - 531752 - Board Meeting Intimation for Compliance Of Regulation 29 Of SEBI (LODR) Regulations, 2015 - Intimation Of Board Meeting.

Biogen Pharmachem's Board of Directors will meet on May 14, 2026. The primary agenda is to consider and approve the audited standalone financial results for the quarter and year ended March 31, 2026.
May 04 2026 17:05:00

Biogen Pharmachem Industries Ltd - 531752 - Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot

Biogen Pharmachem shareholders approved a 1:6 bonus equity share issue. They also approved an increase in authorized share capital and the appointment of M/s. Goenka Mehta & Associates as statutory auditors, with all resolutions passing with over 99% votes.
Apr 27 2026 17:04:00

Biogen Pharmachem Industries Ltd - 531752 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

Biogen Pharmachem shareholders approved a 1:6 bonus equity share issue. They also approved an increase in authorized share capital and the appointment of M/s. Goenka Mehta & Associates as statutory auditors, with all resolutions passing with over 99% votes.
Apr 27 2026 17:04:00
Read More

About Biogen Pharmachem Industries

NSE : 0  
BSE : 531752  
ISIN : INE703D01023  

Biogen Pharmachem Industries Management

NamePosition
Chandrakant Govindbhai ParmarNon Executive Director
Kelash BunkarWhole Time Director & Chief Financial Officer
View More

Biogen Pharmachem Industries FAQs

The Buying Price of Biogen Pharmachem Industries share is 0.37 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Biogen Pharmachem Industries stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Biogen Pharmachem Industries, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Biogen Pharmachem Industries shares is 0. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Biogen Pharmachem Industries shares is 0. Useful to assess the stock's value relative to its book value.

To assess Biogen Pharmachem Industries’s valuation compare Sector P/E, P/B which are 41.49 & 2.06 with sector averages, along with growth rates and financial metrics.

The Market Cap of Biogen Pharmachem Industries is 38.96 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Biogen Pharmachem Industries share price is 0.92 & 0.34. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Biogen Pharmachem Industries belongs to the Miscellaneous sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost